These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 26597111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M, Raymond V, Paradis PE.
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
    Tosanguan J, Chaiyakunapruk N.
    Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
    Hoogendoorn M, Welsing P, Rutten-van Mölken MP.
    Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
    Aumann I, Treskova M, Hagemann N, von der Schulenburg JM.
    Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA, Lovato P, Cuesta G.
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010-2011 Tobacco Use Supplement to the Current Population Survey.
    Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA.
    Drug Alcohol Depend; 2017 Sep 01; 178():485-491. PubMed ID: 28715776
    [Abstract] [Full Text] [Related]

  • 14. An examination of user costs in relation to smokers using a cessation service based in the UK.
    Walker N, Yang Y, Kiparoglou V, Pokhrel S, Robinson H, van Woerden H.
    BMC Health Serv Res; 2018 Mar 15; 18(1):182. PubMed ID: 29544477
    [Abstract] [Full Text] [Related]

  • 15. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
    Connolly MP, Baker CL, Kotsopoulos N.
    J Med Econ; 2018 Jun 15; 21(6):571-576. PubMed ID: 29376747
    [Abstract] [Full Text] [Related]

  • 16. [Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review].
    Aumann I, Rozanski K, Damm K, Graf von der Schulenburg JM.
    Gesundheitswesen; 2016 Oct 15; 78(10):660-671. PubMed ID: 27784123
    [Abstract] [Full Text] [Related]

  • 17. French smoking cessation services provide effective support even to the more dependent.
    Baha M, Boussadi A, Le Faou AL.
    Prev Med; 2016 Sep 15; 90():34-8. PubMed ID: 27346755
    [Abstract] [Full Text] [Related]

  • 18. Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
    Igarashi A, Takuma H, Fukuda T, Tsutani K.
    Pharmacoeconomics; 2009 Sep 15; 27(3):247-61. PubMed ID: 19354344
    [Abstract] [Full Text] [Related]

  • 19. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D, Tappenden P, Peters J, Kenjegalieva K.
    Health Technol Assess; 2009 Sep 15; 13 Suppl 2():9-13. PubMed ID: 19804684
    [Abstract] [Full Text] [Related]

  • 20. Motivational Interviewing to Encourage Quit Attempts Among Smokers Not Ready to Quit: A Trial-Based Economic Analysis.
    Rasu RS, Thelen J, Agbor Bawa W, Goggin K, Bradley-Ewing A, Catley D.
    Nicotine Tob Res; 2020 Aug 24; 22(9):1515-1523. PubMed ID: 31820002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.